← Open Payments lookup

LAMECK SYMEKAH: Open Payments

NPI 1669143525 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,866 in 244 payments from 15 companies in 2025. Trend: 2023 $1,961 · 2024 $3,162 · 2025 $3,866

Food & beverage: $3,759Education: $107
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.29$594
ABBVIE INC.50$560
Neurocrine BioSciences, Inc.18$347
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$314
Teva Pharmaceuticals USA, Inc.15$306
Alkermes, Inc.16$273
Axsome Therapeutics, Inc.13$272
Otsuka America Pharmaceutical, Inc.19$247
E.R. Squibb & Sons, L.L.C.18$226
Takeda Pharmaceuticals U.S.A., Inc.11$209

Products named: FANAPT, VRAYLAR, INGREZZA, CAPLYTA, REXULTI, ARISTADA, Auvelity, COBENFY.

Industry payments across TX — which companies pay providers there.